Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nedd4 family interacting protein 1 (NDFIP1) is an evolutionarily conserved integral Golgi membrane protein characterized by three transmembrane domains and serves as an adaptor for the Nedd4 family of E3 ubiquitin-protein ligases[1][3]. It plays a critical role in regulating the ubiquitination and turnover of various substrates by recruiting Nedd4 family ligases such as NEDD4, ITCH, and NEDD4L, thereby influencing protein stability, vesicle trafficking, immune cell activation, and inflammation[3][4]. NDFIP1 helps maintain immune tolerance by promoting the degradation of specific signaling proteins in T cells and preventing chronic inflammation, as well as modulating pancreatic beta cell survival and cytokine responses. Pathologically, it has been implicated in breast cancer, immune disorders, and neurological conditions, but is not directly targeted by therapeutic drugs at this time[3][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nedd4 family interacting protein 1 (NDFIP1).